Minimal change in HSV-2 seroreactivity: A cross-sectional Swedish population study

The prevalence of antibodies to herpes simplex virus type 2 (HSV-2) was determined in sera collected from 2 Swedish cross-sectional populations during 1990/91 and 1996/97. A glycoprotein G2 (gG-2) peptide ELISA was used to analyse 2899 sera from adults. We found a prevalence of 13.0% in 18-70-y-olds...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scandinavian journal of infectious diseases 2006, Vol.38 (5), p.357-365, Article 357
Hauptverfasser: Jonsson, Maria K., Levi, Michael, Rudén, Ulla, Wahren, Britta
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 365
container_issue 5
container_start_page 357
container_title Scandinavian journal of infectious diseases
container_volume 38
creator Jonsson, Maria K.
Levi, Michael
Rudén, Ulla
Wahren, Britta
description The prevalence of antibodies to herpes simplex virus type 2 (HSV-2) was determined in sera collected from 2 Swedish cross-sectional populations during 1990/91 and 1996/97. A glycoprotein G2 (gG-2) peptide ELISA was used to analyse 2899 sera from adults. We found a prevalence of 13.0% in 18-70-y-olds in 1990/91 and 16.4% in 31-55-y-olds in 1996/97. Seropositivity to HSV-2 was somewhat higher in women than in men; 14.4% compared to 11.6% in 1990/91 and 18.9% compared to 13.6% in 1996/97. Overall there was a significant difference in female prevalence of HSV-2 compared to prevalence in males of the same age groups (p=0.013). Total antibody prevalence to HSV-1 of 88% in HSV-2 negative individuals above 18 y of age was found. HSV-2 positive individuals were found seropositive to HSV-1 in approximately 95% of the cases. 12% were negative for both HSV-1 and HSV-2 antibodies. In addition, there was no serological sign that the reported increase of HSV-1 as an early sexual disease had reduced the frequency of HSV-2 seropositivity in the sexually most active age groups. In conclusion, our investigation has shown no significant increase of HSV-2 seroprevalence in randomly selected Swedish subjects during the defined time period.
doi_str_mv 10.1080/00365540500488865
format Article
fullrecord <record><control><sourceid>proquest_pasca</sourceid><recordid>TN_cdi_pascalfrancis_primary_17730757</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67991515</sourcerecordid><originalsourceid>FETCH-LOGICAL-c503t-60a9a1f422daa052cce0a91254f007e197b15caa3f59d192f2141f4db41bc5cb3</originalsourceid><addsrcrecordid>eNqFkk9v1DAQxS0EotvCB-CCcoFbYOzEcQJcqqp_kIqQKHC1Jo7Dunjj1Ha62m9fbzdQAdJysvX8e57xPBPygsIbCjW8BSgqzkvgAGVd1xV_RBa04jSnTQ2PyWJ7niegPiCHIVxDwqoCnpIDWgloeFEvyJdPZjArtJla4vBDZ2bILq6-5ywL2juvUUVza-LmXXacKe9CyINOkhuS42qtOxOW2ejGyeJWzEKcus0z8qRHG_TzeT0i385Ov55c5Jefzz-eHF_mikMR8wqwQdqXjHWIwJlSOimU8bIHEJo2oqVcIRY9bzrasJ7RMuFdW9JWcdUWRyTf3RvWepxaOfr0EL-RDo2cpZ9ppyUXnNeQ-Nc7fvTuZtIhypUJSluLg3ZTkJVoGsop_y9IBWNlmmAC6Q68H43X_e8eKMhtQvKfhJLn5Xz51K509-CYI0nAqxnAoND2HgdlwgMnRAGCi8SJv4orE-9jiB6N3dvCh53TDL3zK1w7bzsZcWOd_1Wu2Gd__4d9qdHGpUKv5bWbfPoaYU_xO0NszrA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17224670</pqid></control><display><type>article</type><title>Minimal change in HSV-2 seroreactivity: A cross-sectional Swedish population study</title><source>MEDLINE</source><source>Taylor &amp; Francis Medical Library - CRKN</source><source>Taylor &amp; Francis Journals Complete</source><creator>Jonsson, Maria K. ; Levi, Michael ; Rudén, Ulla ; Wahren, Britta</creator><creatorcontrib>Jonsson, Maria K. ; Levi, Michael ; Rudén, Ulla ; Wahren, Britta</creatorcontrib><description>The prevalence of antibodies to herpes simplex virus type 2 (HSV-2) was determined in sera collected from 2 Swedish cross-sectional populations during 1990/91 and 1996/97. A glycoprotein G2 (gG-2) peptide ELISA was used to analyse 2899 sera from adults. We found a prevalence of 13.0% in 18-70-y-olds in 1990/91 and 16.4% in 31-55-y-olds in 1996/97. Seropositivity to HSV-2 was somewhat higher in women than in men; 14.4% compared to 11.6% in 1990/91 and 18.9% compared to 13.6% in 1996/97. Overall there was a significant difference in female prevalence of HSV-2 compared to prevalence in males of the same age groups (p=0.013). Total antibody prevalence to HSV-1 of 88% in HSV-2 negative individuals above 18 y of age was found. HSV-2 positive individuals were found seropositive to HSV-1 in approximately 95% of the cases. 12% were negative for both HSV-1 and HSV-2 antibodies. In addition, there was no serological sign that the reported increase of HSV-1 as an early sexual disease had reduced the frequency of HSV-2 seropositivity in the sexually most active age groups. In conclusion, our investigation has shown no significant increase of HSV-2 seroprevalence in randomly selected Swedish subjects during the defined time period.</description><identifier>ISSN: 0036-5548</identifier><identifier>EISSN: 1651-1980</identifier><identifier>DOI: 10.1080/00365540500488865</identifier><identifier>PMID: 16709538</identifier><identifier>CODEN: SJIDB7</identifier><language>eng</language><publisher>Basingstoke: Informa UK Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Antibodies, Viral - blood ; Biological and medical sciences ; Cross-Sectional Studies ; Enzyme-Linked Immunosorbent Assay - methods ; Female ; Herpes Genitalis - epidemiology ; Herpes Genitalis - transmission ; Herpes Simplex - epidemiology ; Herpes Simplex - transmission ; Herpes simplex virus 1 ; Herpes simplex virus 2 ; Herpesvirus 1, Human - immunology ; Herpesvirus 2, Human - immunology ; Humans ; Infectious diseases ; Male ; Medical sciences ; Middle Aged ; Seroepidemiologic Studies ; Sex Factors ; Sweden - epidemiology</subject><ispartof>Scandinavian journal of infectious diseases, 2006, Vol.38 (5), p.357-365, Article 357</ispartof><rights>2006 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2006</rights><rights>2006 INIST-CNRS</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c503t-60a9a1f422daa052cce0a91254f007e197b15caa3f59d192f2141f4db41bc5cb3</citedby><cites>FETCH-LOGICAL-c503t-60a9a1f422daa052cce0a91254f007e197b15caa3f59d192f2141f4db41bc5cb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.1080/00365540500488865$$EPDF$$P50$$Ginformahealthcare$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.1080/00365540500488865$$EHTML$$P50$$Ginformahealthcare$$H</linktohtml><link.rule.ids>230,314,778,782,883,4012,27910,27911,27912,59632,59738,60421,60527,61206,61241,61387,61422</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17730757$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16709538$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:1932280$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Jonsson, Maria K.</creatorcontrib><creatorcontrib>Levi, Michael</creatorcontrib><creatorcontrib>Rudén, Ulla</creatorcontrib><creatorcontrib>Wahren, Britta</creatorcontrib><title>Minimal change in HSV-2 seroreactivity: A cross-sectional Swedish population study</title><title>Scandinavian journal of infectious diseases</title><addtitle>Scand J Infect Dis</addtitle><description>The prevalence of antibodies to herpes simplex virus type 2 (HSV-2) was determined in sera collected from 2 Swedish cross-sectional populations during 1990/91 and 1996/97. A glycoprotein G2 (gG-2) peptide ELISA was used to analyse 2899 sera from adults. We found a prevalence of 13.0% in 18-70-y-olds in 1990/91 and 16.4% in 31-55-y-olds in 1996/97. Seropositivity to HSV-2 was somewhat higher in women than in men; 14.4% compared to 11.6% in 1990/91 and 18.9% compared to 13.6% in 1996/97. Overall there was a significant difference in female prevalence of HSV-2 compared to prevalence in males of the same age groups (p=0.013). Total antibody prevalence to HSV-1 of 88% in HSV-2 negative individuals above 18 y of age was found. HSV-2 positive individuals were found seropositive to HSV-1 in approximately 95% of the cases. 12% were negative for both HSV-1 and HSV-2 antibodies. In addition, there was no serological sign that the reported increase of HSV-1 as an early sexual disease had reduced the frequency of HSV-2 seropositivity in the sexually most active age groups. In conclusion, our investigation has shown no significant increase of HSV-2 seroprevalence in randomly selected Swedish subjects during the defined time period.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Antibodies, Viral - blood</subject><subject>Biological and medical sciences</subject><subject>Cross-Sectional Studies</subject><subject>Enzyme-Linked Immunosorbent Assay - methods</subject><subject>Female</subject><subject>Herpes Genitalis - epidemiology</subject><subject>Herpes Genitalis - transmission</subject><subject>Herpes Simplex - epidemiology</subject><subject>Herpes Simplex - transmission</subject><subject>Herpes simplex virus 1</subject><subject>Herpes simplex virus 2</subject><subject>Herpesvirus 1, Human - immunology</subject><subject>Herpesvirus 2, Human - immunology</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Seroepidemiologic Studies</subject><subject>Sex Factors</subject><subject>Sweden - epidemiology</subject><issn>0036-5548</issn><issn>1651-1980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkk9v1DAQxS0EotvCB-CCcoFbYOzEcQJcqqp_kIqQKHC1Jo7Dunjj1Ha62m9fbzdQAdJysvX8e57xPBPygsIbCjW8BSgqzkvgAGVd1xV_RBa04jSnTQ2PyWJ7niegPiCHIVxDwqoCnpIDWgloeFEvyJdPZjArtJla4vBDZ2bILq6-5ywL2juvUUVza-LmXXacKe9CyINOkhuS42qtOxOW2ejGyeJWzEKcus0z8qRHG_TzeT0i385Ov55c5Jefzz-eHF_mikMR8wqwQdqXjHWIwJlSOimU8bIHEJo2oqVcIRY9bzrasJ7RMuFdW9JWcdUWRyTf3RvWepxaOfr0EL-RDo2cpZ9ppyUXnNeQ-Nc7fvTuZtIhypUJSluLg3ZTkJVoGsop_y9IBWNlmmAC6Q68H43X_e8eKMhtQvKfhJLn5Xz51K509-CYI0nAqxnAoND2HgdlwgMnRAGCi8SJv4orE-9jiB6N3dvCh53TDL3zK1w7bzsZcWOd_1Wu2Gd__4d9qdHGpUKv5bWbfPoaYU_xO0NszrA</recordid><startdate>2006</startdate><enddate>2006</enddate><creator>Jonsson, Maria K.</creator><creator>Levi, Michael</creator><creator>Rudén, Ulla</creator><creator>Wahren, Britta</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope></search><sort><creationdate>2006</creationdate><title>Minimal change in HSV-2 seroreactivity: A cross-sectional Swedish population study</title><author>Jonsson, Maria K. ; Levi, Michael ; Rudén, Ulla ; Wahren, Britta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c503t-60a9a1f422daa052cce0a91254f007e197b15caa3f59d192f2141f4db41bc5cb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Antibodies, Viral - blood</topic><topic>Biological and medical sciences</topic><topic>Cross-Sectional Studies</topic><topic>Enzyme-Linked Immunosorbent Assay - methods</topic><topic>Female</topic><topic>Herpes Genitalis - epidemiology</topic><topic>Herpes Genitalis - transmission</topic><topic>Herpes Simplex - epidemiology</topic><topic>Herpes Simplex - transmission</topic><topic>Herpes simplex virus 1</topic><topic>Herpes simplex virus 2</topic><topic>Herpesvirus 1, Human - immunology</topic><topic>Herpesvirus 2, Human - immunology</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Seroepidemiologic Studies</topic><topic>Sex Factors</topic><topic>Sweden - epidemiology</topic><toplevel>online_resources</toplevel><creatorcontrib>Jonsson, Maria K.</creatorcontrib><creatorcontrib>Levi, Michael</creatorcontrib><creatorcontrib>Rudén, Ulla</creatorcontrib><creatorcontrib>Wahren, Britta</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><jtitle>Scandinavian journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jonsson, Maria K.</au><au>Levi, Michael</au><au>Rudén, Ulla</au><au>Wahren, Britta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Minimal change in HSV-2 seroreactivity: A cross-sectional Swedish population study</atitle><jtitle>Scandinavian journal of infectious diseases</jtitle><addtitle>Scand J Infect Dis</addtitle><date>2006</date><risdate>2006</risdate><volume>38</volume><issue>5</issue><spage>357</spage><epage>365</epage><pages>357-365</pages><artnum>357</artnum><issn>0036-5548</issn><eissn>1651-1980</eissn><coden>SJIDB7</coden><abstract>The prevalence of antibodies to herpes simplex virus type 2 (HSV-2) was determined in sera collected from 2 Swedish cross-sectional populations during 1990/91 and 1996/97. A glycoprotein G2 (gG-2) peptide ELISA was used to analyse 2899 sera from adults. We found a prevalence of 13.0% in 18-70-y-olds in 1990/91 and 16.4% in 31-55-y-olds in 1996/97. Seropositivity to HSV-2 was somewhat higher in women than in men; 14.4% compared to 11.6% in 1990/91 and 18.9% compared to 13.6% in 1996/97. Overall there was a significant difference in female prevalence of HSV-2 compared to prevalence in males of the same age groups (p=0.013). Total antibody prevalence to HSV-1 of 88% in HSV-2 negative individuals above 18 y of age was found. HSV-2 positive individuals were found seropositive to HSV-1 in approximately 95% of the cases. 12% were negative for both HSV-1 and HSV-2 antibodies. In addition, there was no serological sign that the reported increase of HSV-1 as an early sexual disease had reduced the frequency of HSV-2 seropositivity in the sexually most active age groups. In conclusion, our investigation has shown no significant increase of HSV-2 seroprevalence in randomly selected Swedish subjects during the defined time period.</abstract><cop>Basingstoke</cop><pub>Informa UK Ltd</pub><pmid>16709538</pmid><doi>10.1080/00365540500488865</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0036-5548
ispartof Scandinavian journal of infectious diseases, 2006, Vol.38 (5), p.357-365, Article 357
issn 0036-5548
1651-1980
language eng
recordid cdi_pascalfrancis_primary_17730757
source MEDLINE; Taylor & Francis Medical Library - CRKN; Taylor & Francis Journals Complete
subjects Adolescent
Adult
Aged
Antibodies, Viral - blood
Biological and medical sciences
Cross-Sectional Studies
Enzyme-Linked Immunosorbent Assay - methods
Female
Herpes Genitalis - epidemiology
Herpes Genitalis - transmission
Herpes Simplex - epidemiology
Herpes Simplex - transmission
Herpes simplex virus 1
Herpes simplex virus 2
Herpesvirus 1, Human - immunology
Herpesvirus 2, Human - immunology
Humans
Infectious diseases
Male
Medical sciences
Middle Aged
Seroepidemiologic Studies
Sex Factors
Sweden - epidemiology
title Minimal change in HSV-2 seroreactivity: A cross-sectional Swedish population study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T10%3A15%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Minimal%20change%20in%20HSV-2%20seroreactivity:%20A%20cross-sectional%20Swedish%20population%20study&rft.jtitle=Scandinavian%20journal%20of%20infectious%20diseases&rft.au=Jonsson,%20Maria%20K.&rft.date=2006&rft.volume=38&rft.issue=5&rft.spage=357&rft.epage=365&rft.pages=357-365&rft.artnum=357&rft.issn=0036-5548&rft.eissn=1651-1980&rft.coden=SJIDB7&rft_id=info:doi/10.1080/00365540500488865&rft_dat=%3Cproquest_pasca%3E67991515%3C/proquest_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17224670&rft_id=info:pmid/16709538&rfr_iscdi=true